Application of medical cannabis in unstable angina and coronary artery disease: A case report.

ABSTRACT:

Rationale

First discovered in 1990, the endocannabinoid system (ECS) was initially shown to have an intimate relationship with central areas of the nervous system associated with pain, reward, and motivation. Recently, however, the ECS has been extensively implicated in the cardiovascular system with contractility, heart rate, blood pressure, and vasodilation. Emerging data demonstrate modulation of the ECS plays an essential role in cardio metabolic risk, atherosclerosis, and can even limit damage to cardiomyocytes during ischemic events.

Patient concerns

This case describes a 63-year-old man who presented to a primary care physician for a medical cannabis (MC) consult due to unstable angina (UA) not relieved by morphine or cardiac medications; having failed all first- and

SUBMITTER: Shaffer BL 

PROVIDER: S-EPMC7982176 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature